Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Resistance”

1,038 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,038 results

Post-approval studies (Phase 4)UnknownNCT03057470
What this trial is testing

Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)

Who this might be right for
Diabetes Mellitus, Type 1
LMC Diabetes & Endocrinology Ltd. 18
Not applicableLooking for participantsNCT04243720
What this trial is testing

Immune Resistance Interrogation Study

Who this might be right for
CancerSolid TumorMetastatic Cancer+1 more
University Health Network, Toronto 100
Post-approval studies (Phase 4)Study completedNCT00145379
What this trial is testing

The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00553488
What this trial is testing

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

Who this might be right for
Diabetes Mellitus, Type 1
Becton, Dickinson and Company 30
Early research (Phase 1)Study completedNCT00024986
What this trial is testing

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00484627
What this trial is testing

Effects of Creatine and Resistance Exercise Training in People With HIV Infection

Who this might be right for
HIV Infections
National Center for Complementary and Integrative Health (NCCIH) 43
Not applicableStudy completedNCT05805969
What this trial is testing

Accommodating Variable-Resistance Training in Patients With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Cairo University 58
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Not applicableLooking for participantsNCT06875167
What this trial is testing

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Who this might be right for
Type 1 DiabetesClosed LoopInsulin+2 more
Fondation Lenval 20
Very early researchLooking for participantsNCT06609356
What this trial is testing

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more
Vanderbilt University Medical Center 27
Not applicableStudy completedNCT00046267
What this trial is testing

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Early research (Phase 1)UnknownNCT06568328
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Who this might be right for
Graft vs Host Disease
Fujian Medical University 17
Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Early research (Phase 1)WithdrawnNCT03773328
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Cellenkos, Inc.
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Not applicableNot Yet RecruitingNCT06617351
What this trial is testing

This Repeated Measures Parallel-group Investigation Will Examine the Influence of Short-term Melatonin Supplementation (5mg, 3 x Day for 72 Hours) on Cellular Responses, Functional Performance and Recovery Following an Acute Bout of Dynamic Resistance Exercise in Resistance Trained Men and Women

Who this might be right for
Cell MigrationCell InvasionExercise Recovery
University of Central Florida 24
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Next Page